
Molecule: LEBRIKIZUMAB
ChEMBL ID: CHEMBL1743035
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: TRALOKINUMAB
ChEMBL ID: CHEMBL1743081
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2021

Molecule: ANRUKINZUMAB
ChEMBL ID: CHEMBL1742985
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: QAX-576
ChEMBL ID: CHEMBL2109465
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: TNX-650
ChEMBL ID: CHEMBL2109466
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: CNTO-5825
ChEMBL ID: CHEMBL2109464
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody

Molecule: ROMILKIMAB
ChEMBL ID: CHEMBL4298097
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: CENDAKIMAB
ChEMBL ID: CHEMBL4297864
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: CINTREDEKIN BESUDOTOX
ChEMBL ID: CHEMBL2108583
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Protein

Molecule: CINTREDEKIN BESUDOTOX
ChEMBL ID: CHEMBL2108583
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Protein
